Are nanobiosensors an improved solution for diagnosis of Leishmania?

Detalhes bibliográficos
Autor(a) principal: Jain, Sona
Data de Publicação: 2021
Outros Autores: Santana, Wanessa, Dolabella, Silvio S., Santos, André L. S., Souto, Eliana B., Severino, Patrícia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/71924
Resumo: Leishmaniasis is one of the deadliest neglected tropical diseases affecting 1215 million people worldwide, especially in middle- and low-income countries. Rapid and accurate diagnosis of the disease is important for its adequate management and treatment. Several techniques are available for the diagnosis of leishmaniasis. Among these, parasitological and immunological tests are most widely used. However, in most cases, the utilized diagnostic techniques are not good enough, showing cross-reactivity and reduced accuracy. In recent years, many new methods have been reported with potential for improved diagnosis. This review focuses on the diagnosis of Leishmania exploring the biosensors and nanotechnology-based options for their detection. New developments including the use of nanomaterials as fluorophores, fluorescence quenchers as reducing agents and as dendrimers for signal improvement and amplification, together with the use of aptamers to replace antibodies are described. Future research opportunities to overcome the current limitations on the available diagnostic approaches are also discussed.
id RCAP_7092cf38e3b3d8deac0907459065087b
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/71924
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Are nanobiosensors an improved solution for diagnosis of Leishmania?aloe verachitosan membranewound healingcolor parametersmoisture vapor transmission ratetensile strengthleishmaniasisnanomaterialsimmunosensorsgenosensorsparasitic diseasesScience & TechnologyLeishmaniasis is one of the deadliest neglected tropical diseases affecting 1215 million people worldwide, especially in middle- and low-income countries. Rapid and accurate diagnosis of the disease is important for its adequate management and treatment. Several techniques are available for the diagnosis of leishmaniasis. Among these, parasitological and immunological tests are most widely used. However, in most cases, the utilized diagnostic techniques are not good enough, showing cross-reactivity and reduced accuracy. In recent years, many new methods have been reported with potential for improved diagnosis. This review focuses on the diagnosis of Leishmania exploring the biosensors and nanotechnology-based options for their detection. New developments including the use of nanomaterials as fluorophores, fluorescence quenchers as reducing agents and as dendrimers for signal improvement and amplification, together with the use of aptamers to replace antibodies are described. Future research opportunities to overcome the current limitations on the available diagnostic approaches are also discussed.This work was supported by São Paulo Research Foundation (FAPESP) (2010/17.721-4), Portuguese Science and Technology Foundation (FCT) through the projects M-ERA-NET/0004/2015 (PAIRED) and UIDB/04469/2020 (strategic fund) funded by national funds, and co-financed Educa tion (FCT/MEC) from national funds and FEDER, under the Partnership Agreement PT202info:eu-repo/semantics/publishedVersionMultidisciplinary Digital Publishing Institute (MDPI)Universidade do MinhoJain, SonaSantana, WanessaDolabella, Silvio S.Santos, André L. S.Souto, Eliana B.Severino, Patrícia20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/71924engJain, Sona; Santana, Wanessa; Dolabella, Silvio S.; Santos, André L. S.; Souto, Eliana; Severino, Patrícia, Are nanobiosensors an improved solution for diagnosis of Leishmania?. Pharmaceutics, 13(4), 491, 20211999-492310.3390/pharmaceutics13040491https://www.mdpi.com/1999-4923/13/4/491info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:52:34Zoai:repositorium.sdum.uminho.pt:1822/71924Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:51:43.989882Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Are nanobiosensors an improved solution for diagnosis of Leishmania?
title Are nanobiosensors an improved solution for diagnosis of Leishmania?
spellingShingle Are nanobiosensors an improved solution for diagnosis of Leishmania?
Jain, Sona
aloe vera
chitosan membrane
wound healing
color parameters
moisture vapor transmission rate
tensile strength
leishmaniasis
nanomaterials
immunosensors
genosensors
parasitic diseases
Science & Technology
title_short Are nanobiosensors an improved solution for diagnosis of Leishmania?
title_full Are nanobiosensors an improved solution for diagnosis of Leishmania?
title_fullStr Are nanobiosensors an improved solution for diagnosis of Leishmania?
title_full_unstemmed Are nanobiosensors an improved solution for diagnosis of Leishmania?
title_sort Are nanobiosensors an improved solution for diagnosis of Leishmania?
author Jain, Sona
author_facet Jain, Sona
Santana, Wanessa
Dolabella, Silvio S.
Santos, André L. S.
Souto, Eliana B.
Severino, Patrícia
author_role author
author2 Santana, Wanessa
Dolabella, Silvio S.
Santos, André L. S.
Souto, Eliana B.
Severino, Patrícia
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Jain, Sona
Santana, Wanessa
Dolabella, Silvio S.
Santos, André L. S.
Souto, Eliana B.
Severino, Patrícia
dc.subject.por.fl_str_mv aloe vera
chitosan membrane
wound healing
color parameters
moisture vapor transmission rate
tensile strength
leishmaniasis
nanomaterials
immunosensors
genosensors
parasitic diseases
Science & Technology
topic aloe vera
chitosan membrane
wound healing
color parameters
moisture vapor transmission rate
tensile strength
leishmaniasis
nanomaterials
immunosensors
genosensors
parasitic diseases
Science & Technology
description Leishmaniasis is one of the deadliest neglected tropical diseases affecting 1215 million people worldwide, especially in middle- and low-income countries. Rapid and accurate diagnosis of the disease is important for its adequate management and treatment. Several techniques are available for the diagnosis of leishmaniasis. Among these, parasitological and immunological tests are most widely used. However, in most cases, the utilized diagnostic techniques are not good enough, showing cross-reactivity and reduced accuracy. In recent years, many new methods have been reported with potential for improved diagnosis. This review focuses on the diagnosis of Leishmania exploring the biosensors and nanotechnology-based options for their detection. New developments including the use of nanomaterials as fluorophores, fluorescence quenchers as reducing agents and as dendrimers for signal improvement and amplification, together with the use of aptamers to replace antibodies are described. Future research opportunities to overcome the current limitations on the available diagnostic approaches are also discussed.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/71924
url http://hdl.handle.net/1822/71924
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Jain, Sona; Santana, Wanessa; Dolabella, Silvio S.; Santos, André L. S.; Souto, Eliana; Severino, Patrícia, Are nanobiosensors an improved solution for diagnosis of Leishmania?. Pharmaceutics, 13(4), 491, 2021
1999-4923
10.3390/pharmaceutics13040491
https://www.mdpi.com/1999-4923/13/4/491
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute (MDPI)
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133106639208448